Establishment Labs Holdings ESTA 深 滬
等待開盤 09-09 09:30:00 美东时间
74.04
-0.250
-0.34%
華盛通- 最 高75.105
- 今 開74.08
- 成交量 11.83万股
- 最 低 72.3146
- 昨 收 74.29
- 總市值 22.07亿
- 52周最高 97.59
- 市盈率 靜 --
- 換手率 0.40%
- 52周最低 36.61
- 委 比 -15.25%
- 總股本 2980.19万
- 歷史最高 97.59
- 量 比 0.62
- 振 幅 3.76%
- 歷史最低 7.56
- 每 手 1
- 風險率 14.30%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多美股大行评级 | 美银上调微软目标价从500美元升至600美元；BlossomHill获小摩等多家大行首予买入评级
今日重点评级关注：BTIG：维持Kazia Therapeutics"买入"评级，目标价从34美元升至40美元；摩根大通：维持Annexon"超配"评级，目标价从10美元升至14美元
09-02 14:07
BTIG Reiterates Buy on Establishment Labs Hldgs, Maintains $103 Price Target
BTIG analyst Sam Eiber reiterates Establishment Labs Hldgs (NASDAQ:ESTA) with a Buy and maintains $103 price target.
09-01 17:56
Royce Micro-Cap Trust (NYSE: RMT) as of Jul 31, 2026
Average weekly trading volume of approximately 674,921 shares Fund's adviser has more than 50 years of small- and micro-cap investment experience NEW YORK, Aug. 25, 2026 /PRNewswire/ -- CLOS...
08-26 02:13
美股大行评级 | 潜在涨幅544.53%！Scynexis获古根海姆升目标价至33美元，维持"买入"评级
今日重点评级关注：古根海姆：维持Scynexis"买入"评级，目标价从24美元升至33美元；韦德布什：维持Kura Oncology"跑赢大市"评级，目标价从36美元升至38美元
08-14 11:51
Citigroup Upgrades Establishment Labs Hldgs to Buy, Maintains Price Target to $92
Citigroup analyst Joanne Wuensch upgrades Establishment Labs Hldgs (NASDAQ:ESTA) from Neutral to Buy and maintains the price target from $92 to $92.
08-14 02:39
The Galien Foundation Announces 2026 Prix Galien USA Nominees for "Best Digital Health Solution," "Best Medical Technology," "Incubators, Accelerators and Equity," and "Best Startup"
Celebrating 20 Years of Honoring the Digital Breakthroughs, Pioneering Startups, and Ecosystems Driving the Future of Healthcare NEW YORK, Aug. 13, 2026 /PRNewswire/ -- The Galien Foundation...
08-13 21:00
Analysts’ Top Healthcare Picks: Qiagen (QGEN), Establishment Labs Holdings (ESTA)
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts jus...
08-11 20:20
美股大行评级 | 花旗下调美光科技目标价从1400美元降至1150美元；爱彼迎、Datadog、Cloudflare、Etsy、Natera、拉夫劳伦获多家大行上调目标价
今日重点评级关注：康托·菲茨杰拉德：维持InflaRx"超配"评级，目标价从4美元升至6美元；RBC Capital：维持Nuvation Bio"跑赢大市"评级，目标价从19美元升至20美元
08-10 19:24
财报速睇 | Establishment Labs Holdings 2026财年Q2营收0.68亿美元，同比增长33.3%；归母净利润亏损0.12亿美元，同比亏损缩窄29.4%
华盛资讯8月8日讯，Establishment Labs Holdings公布2026财年Q2业绩，公司Q2营收0.68亿美元，同比增长33.3%，归母净利润亏损0.12亿美元，同比亏损缩窄29.4%。
08-08 04:17
财报速睇 | Establishment Labs Holdings 2026财年Q2营收0.68亿美元，同比增长31.7%；归母净利润亏损0.12亿美元，同比亏损缩窄29.2%
华盛资讯8月6日讯，Establishment Labs Holdings公布2026财年Q2业绩，公司Q2营收0.68亿美元，同比增长31.7%，归母净利润亏损0.12亿美元，同比亏损缩窄29.2%。
08-06 20:23
